20130621 health techsummit
-
Upload
medtech-europe -
Category
Business
-
view
384 -
download
4
description
Transcript of 20130621 health techsummit
![Page 1: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/1.jpg)
Upcoming changes in EU medical device regulation
The future of MedTech innovation in Europe at stake
HealthTech Summit, 26 June 2013, London
![Page 2: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/2.jpg)
www.dontlosethe3.eu
2
![Page 3: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/3.jpg)
How does Europe work?
3
![Page 4: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/4.jpg)
What industry wants to achieve
Industry wants a clear, predictable and effective
regulatory system specifically tailored for medical devices
4
1. SAFETY 2. TIMELY ACCESS
3. TRUST
4. SUSTAINABILITY
5. INNOVATION
![Page 5: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/5.jpg)
What industry proposes
Improve decentralised device-specific approval system
5
1. NOTIFIED BODIES
2. ENFORCEMENT
3. CLINICAL REQUIREMENTS
NO PMA
![Page 6: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/6.jpg)
Where are we today?
1. European Commission has “scrutiny” in proposal
2. European Parliament has centralised PMA system in
draft report
But more than 700 amendments
Vote on 10 July (plenary in September)
3. EU Council position and timeline unclear
6
![Page 7: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/7.jpg)
Maintain investment & innovation in Europe
Europe needs an approval system that ensures
1. High safety
2. Timely market access
3. Predictability
4. Reasonable approval costs
5. Incentives to innovate
7
Improved
Decentralised
Approval
System
![Page 8: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/8.jpg)
What will the future look like?
Best case:
Improved decentralised approval system
Continuous timely innovation cycles
Supportive of SMEs, startups
Worst case:
Slow, bureaucratic centralised approval system
Lengthy, unpredictable approval delays
Detrimental to small innovators
8
![Page 9: 20130621 health techsummit](https://reader036.fdocuments.us/reader036/viewer/2022081907/54817885b4795994578b48bf/html5/thumbnails/9.jpg)